Uroplasty misses by $0.01, misses on revenue

Uroplasty (UPI): FQ4 EPS of -$0.05 misses by $0.01.

Revenue of $6.36M (+15% Y/Y) misses by $0.02M.

Comments (1)
  • stevetiger
    , contributor
    Comments (2) | Send Message
    Company turn around experience with three smaller companies. Prior to that held numerous marketing and sales positions... including VP Sales with two fortune 500 companies. Currently am majority shareholder of Atrix International.
    18 May 2014, 09:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs